Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04338685
What this trial is testing

A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases

Who this might be right for
Carcinoma, HepatocellularBiliary Tract CancerSecondary Liver Cancer+1 more
Hoffmann-La Roche 55
Early research (Phase 1)Study completedNCT03358849
What this trial is testing

Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Yonsei University 9
Testing effectiveness (Phase 2)UnknownNCT03311789
What this trial is testing

Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCs

Who this might be right for
Biliary Tract Cancer
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00003276
What this trial is testing

Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer

Who this might be right for
Gallbladder Cancer
Alliance for Clinical Trials in Oncology 40
Testing effectiveness (Phase 2)Looking for participantsNCT07433673
What this trial is testing

Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

Who this might be right for
Colon and Rectal Cancer
Columbia University 20
Early research (Phase 1)Looking for participantsNCT06546969
What this trial is testing

Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
University of Maryland, Baltimore 15
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07310069
What this trial is testing

Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer

Who this might be right for
Gallbladder Cancer Unresectable
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 44
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT06013943
What this trial is testing

Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC

Who this might be right for
Gallbladder Cancer
Eastern Hepatobiliary Surgery Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05820906
What this trial is testing

Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04298021
What this trial is testing

DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer

Who this might be right for
Bile Duct CancerChemotherapy Effect
Seoul National University Hospital 74
Testing effectiveness (Phase 2)Ended earlyNCT03291899
What this trial is testing

Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer
King Faisal Specialist Hospital & Research Center 13
Testing effectiveness (Phase 2)Study completedNCT01284413
What this trial is testing

Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group 68
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)UnknownNCT05509478
What this trial is testing

Lenvatinib Combined With PD-1 Inhibitors as First-line Treatment for Unresectable/Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Cancer
The First Hospital of Jilin University 46
Large-scale testing (Phase 3)Study completedNCT00939848
What this trial is testing

Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers

Who this might be right for
Biliary Tract Neoplasms
University College, London 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT03801083
What this trial is testing

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

Who this might be right for
Biliary Tract CancerCholangiocarcinomaBiliary Tract Neoplasms
Udai Kammula 4
Not applicableNot Yet RecruitingNCT07830628
What this trial is testing

Bile ctDNA Genomic Profiling and Concordance With Tumor Tissue in Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
CHA University 100
Testing effectiveness (Phase 2)WithdrawnNCT02720601
What this trial is testing

Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer
New Mexico Cancer Research Alliance
Early research (Phase 1)Looking for participantsNCT06043466
What this trial is testing

A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophagus CancerGastric Cancer+4 more
Chongqing Precision Biotech Co., Ltd 30
Next Page